Evidence map›Paper›PMID 38650198›Full record

ArticleBioresources and bioprocessing2021

Tunnel engineering for modulating the substrate preference in cytochrome P450

Shuaiqi Meng, Ruipeng An, Zhongyu Li, Ulrich Schwaneberg, Yu Ji, Mehdi D Davari, Fang Wang, Meng Wang, Meng Qin, Kaili Nie and 1 more

Abstract read
In one paragraph

Article in Bioresources and bioprocessing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. High-level amyrin production inSynthetic and systems biotechnology · 2027
    Article
  4. Article
  5. Empowering Precision C-H Functionalization: Advances in Peroxygenase Engineering.Angewandte Chemie (International ed. in English) · 2026
    Review
  6. Review
  7. Efficient synthesis of l-DOPA inSynthetic and systems biotechnology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shuaiqi Meng *Beijing Bioprocess Key Laboratory, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China.
Ruipeng An *Beijing Bioprocess Key Laboratory, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China.
Zhongyu LiBeijing Bioprocess Key Laboratory, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China.
Ulrich SchwanebergInstitute of Biotechnology, RWTH Aachen University, Worringerweg 3, 52074, Aachen, Germany.
Yu JiInstitute of Biotechnology, RWTH Aachen University, Worringerweg 3, 52074, Aachen, Germany.
Mehdi D DavariInstitute of Biotechnology, RWTH Aachen University, Worringerweg 3, 52074, Aachen, Germany.
Fang WangBeijing Bioprocess Key Laboratory, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China.
Meng WangBeijing Bioprocess Key Laboratory, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China.
Meng QinBeijing Bioprocess Key Laboratory, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China.
Kaili NieBeijing Bioprocess Key Laboratory, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China.
Luo LiuBeijing Bioprocess Key Laboratory, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China. liuluo@mail.buct.edu.cn.ORCID http://orcid.org/0000-0002-3542-8213

Funding

European Union's Horizon 2020 870294National Natural Science Foundation of China 21861132017National Natural Science Foundation of China 21978017National Natural Science Foundation of China 21978020National Natural Science Foundation of China 31961133017
6 · The paper itself

Abstract

An active site is normally located inside enzymes, hence substrates should go through a tunnel to access the active site. Tunnel engineering is a powerful strategy for refining the catalytic properties of enzymes. Here, P450

Indexed as

Cytochrome P450BsβHIRational designSubstrate preferenceTunnel engineeringα-Alkene biosynthesis

Identifiers

PMID38650198
PMCPMC10992877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.